Goldman Sachs’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $786K | Sell |
|
|||||
|
2025
Q1 | $2.2M | Sell |
|
|||||
|
2024
Q4 | $6.06M | Buy |
|
|||||
|
2024
Q3 | $2.16M | Buy |
|
|||||
|
2024
Q2 | $2.03M | Sell |
|
|||||
|
2024
Q1 | $9.02M | Buy |
|
|||||
|
2023
Q4 | $3.16M | Sell |
|
|||||
|
2023
Q3 | $1.15M | Buy |
|
|||||
|
2023
Q2 | $1.15M | Buy |
|
|||||
|
2023
Q1 | $1.11M | Sell |
|
|||||
|
2022
Q4 | $4.54M | Buy |
|
|||||
|
2022
Q3 | $3.12M | Buy |
|
|||||
|
2022
Q2 | $1.66M | Sell |
|
|||||
|
2022
Q1 | $1.72M | Buy |
|
|||||
|
2021
Q4 | $1.44M | Buy |
|
|||||
|
2021
Q3 | $332K | Sell |
|
|||||
|
2021
Q2 | $814K | Buy |
|
|||||
|
2021
Q1 | $497K | Sell |
|
|||||
|
2020
Q4 | $2.55M | Buy |
|
|||||
|
2020
Q3 | $1.69M | Sell |
|
|||||
|
2020
Q2 | $16M | Buy |
|
|||||
|
2020
Q1 | $7.47M | Sell |
|
|||||
|
2019
Q4 | $24.2M | Buy |
|
|||||
|
2019
Q3 | $10.7M | Sell |
|
|||||
|
2019
Q2 | $20.3M | Sell |
|
|||||
|
2019
Q1 | $18.7M | Buy |
|
|||||
|
2018
Q4 | $15.1M | Buy |
|
|||||
|
2018
Q3 | $10.4M | Buy |
|
|||||
|
2018
Q2 | $8.43M | Buy |
|
|||||
|
2018
Q1 | $13.6M | Sell |
|
|||||
|
2017
Q4 | $21.8M | Buy |
|
|||||
|
2017
Q3 | $13M | Buy |
|
|||||
|
2017
Q2 | $11.6M | Buy |
|
|||||
|
2017
Q1 | $2.19M | Buy |
|
|||||
|
2016
Q4 | $529K | Sell |
|
|||||
|
2016
Q3 | $689K | Buy |
|
|||||
|
2016
Q2 | $474K | Buy |
|
|||||
|
2016
Q1 | $694K | Sell |
|
|||||
|
2015
Q4 | $936K | Buy |
|
|||||
|
2015
Q3 | $473K | Buy |
|
|||||
|
2015
Q2 | $939K | Sell |
|
|||||
|
2015
Q1 | $1.5M | Buy |
|
|||||
|
2014
Q4 | $230K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $162K | Sell |
|
|||||
|
2013
Q3 | $316K | Buy |
|